November 30, 2016 - By Winifred Garcia · 0 Comments
Teleflex Inc (NYSE:TFX) institutional sentiment increased to 1.2 in 2016 Q2. Its up 0.16, from 1.04 in 2016Q1. The ratio is more positive, as 161 investment managers started new or increased stock positions, while 155 sold and decreased equity positions in Teleflex Inc. The investment managers in our partner’s database now have: 40.68 million shares, down from 41.20 million shares in 2016Q1. Also, the number of investment managers holding Teleflex Inc in their top 10 stock positions increased from 10 to 11 for an increase of 1. Sold All: 36 Reduced: 119 Increased: 108 New Position: 53.
Teleflex Incorporated is a provider of medical technology products. The company has a market cap of $6.46 billion. The Firm designs, develops, makes and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. It has a 26.85 P/E ratio. The Firm markets and sells its products to hospitals and healthcare providers, across the world, through a combination of its direct sales force and distributors.
The stock decreased 0.30% or $0.45 during the last trading session, hitting $149.64. Teleflex Incorporated (NYSE:TFX) has declined 6.62% since April 27, 2016 and is downtrending. It has underperformed by 11.85% the S&P500.
Analysts await Teleflex Incorporated (NYSE:TFX) to report earnings on February, 23. They expect $2.10 earnings per share, up 4.48% or $0.09 from last year’s $2.01 per share. TFX’s profit will be $90.66M for 17.81 P/E if the $2.10 EPS becomes a reality. After $1.80 actual earnings per share reported by Teleflex Incorporated for the previous quarter, Wall Street now forecasts 16.67% EPS growth.
According to Zacks Investment Research, “Teleflex Inc. designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company offers its products to hospitals and healthcare providers through its direct sales force and distributors. Teleflex was founded in 1943 and is headquartered in Wayne, Pennsylvania.”
Brookside Capital Management Llc holds 5.17% of its portfolio in Teleflex Incorporated for 695,913 shares. Kimelman & Baird Llc owns 141,784 shares or 4.6% of their US portfolio. Moreover, Solaris Asset Management Llc has 3.63% invested in the company for 28,407 shares. The Massachusetts-based Copper Rock Capital Partners Llc has invested 3.06% in the stock. Mountain Pacific Investment Advisers Inc Id, a Idaho-based fund reported 150,148 shares.#img1#
Insider Transactions: Since January 1, 0001, the stock had 0 insider buys, and 1 insider sale for $132,378 net activity.
Ratings analysis reveals 100% of Teleflex’s analysts are positive. Out of 4 Wall Street analysts rating Teleflex, 4 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $145 while the high is $183. The stock’s average target of $165.25 is 10.43% above today’s ($149.64) share price. TFX was included in 9 notes of analysts from July 31, 2015. Brean Capital maintained Teleflex Incorporated (NYSE:TFX) rating on Friday, July 31. Brean Capital has “Buy” rating and $145 price target. The firm earned “Buy” rating on Friday, February 26 by Brean Capital. The stock of Teleflex Incorporated (NYSE:TFX) has “Overweight” rating given on Tuesday, June 14 by Barclays Capital. As per Friday, March 11, the company rating was maintained by Brean Capital. The stock has “Overweight” rating given by Piper Jaffray on Monday, November 30. The firm has “Buy” rating given on Thursday, April 28 by Brean Capital. Raymond James upgraded the shares of TFX in a report on Wednesday, January 6 to “Strong Buy” rating.
Teleflex Incorporated, incorporated on June 25, 1943, is a well-known provider of medical technology products. The Firm designs, develops, makes and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Firm markets and sells its products to hospitals and healthcare providers, across the world, through a combination of its direct sales force and distributors. The Firm operates through six divisions: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM). The Firm makes its products at approximately 30 manufacturing sites, with manufacturing activities located in the Czech Republic, Germany, Malaysia, Mexico and the United States.
More recent Teleflex Incorporated (NYSE:TFX) news were published by: Businesswire.com which released: “Teleflex Incorporated Announces Worldwide Recall of ARROW® International Intra …” on March 11, 2016. Also Moodys.com published the news titled: “Moody’s rates Teleflex notes Ba3; stable outlook” on May 11, 2016. Businesswire.com‘s news article titled: “Teleflex Acquisition of Nostix, LLC Expands Catheter Tip Placement Solutions” with publication date: January 11, 2016 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Winifred Garcia